Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system

Brain, Behavior, and Immunity

Volumn 25, Issue 8, 2011, Pages 1592-1606

  Skripuletz, Thomas ^a   Miller, Elvira ^a   Grote, Lisa ^a   Gudi, Viktoria ^a,b   Pul, Refik ^a   Voss, Elke ^a   Škuljec, Jelena ^a,b   Moharregh Khiabani, Darius ^a   Trebst, Corinna ^a   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

C57BL 6 mice; Cuprizone; LPS; Microglia; Remyelination

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CUPRIZONE; LIPOPOLYSACCHARIDE; MYELIN PROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION;

ANIMALS; AXONS; CELL COUNT; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHELATING AGENTS; CUPRIZONE; DEMYELINATING DISEASES; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MYELIN SHEATH; NEURAL STEM CELLS; OLIGODENDROGLIA; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80053913473     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.05.009     Document Type: Article

References (51)

1. Armstrong R.C., Le T.Q., Frost E.E., Borke R.C., Vana A.C. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci. 2002, 22:8574-8585.
2. Bakker D.A., Ludwin S.K. Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J. Neurol. Sci. 1987, 78:125-137.
3. Banks W.A., Robinson S.M. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain. Behav. Immun. 2010, 24:102-109.
4. Barres B.A., Burne J.F., Holtmann B., Thoenen H., Sendtner M., Raff M.C. Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol. Cell Neurosci. 1996, 8:146-156.
5. Bianco F., Ceruti S., Colombo A., Fumagalli M., Ferrari D., Pizzirani C., Matteoli M., Di Virgilio F., Abbracchio M.P., Verderio C. A role for P2X7 in microglial proliferation. J. Neurochem. 2006, 99:745-758.
6. Boven L.A., van Meurs M., Van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., Laman J.D. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006, 129:517-526.
7. Buenafe A.C., Bourdette D.N. Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007, 182:32-40.
8. Chakravarty S., Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 2005, 25:1788-1796.
9. Chen G., McCuskey R.S., Reichlin S. Blood interleukin-6 and tumor necrosis factor-α elevation after intracerebroventricular injection of Escherichia coli endotoxin in the rat is determined by two opposing factors: peripheral induction by LPS transferred from brain to blood and inhibition of peripheral response by a brain-mediated mechanism. Neuroimmunomodulation. 2000, 8:59-69.
10. Ellestad K.K., Tsutsui S., Noorbakhsh F., Warren K.G., Yong V.W., Pittman Q.J., Power C. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J. Immunol. 2009, 183:298-309.
11. Ganter S., Northoff H., Mannel D., Gebicke-Harter P.J. Growth control of cultured microglia. J. Neurosci.Res. 1992, 33:218-230.
12. Gebicke-Haerter P.J., Bauer J., Schobert A., Northoff H. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J. Neurosci. 1989, 9:183-194.
13. Gudi V., Moharregh-Khiabani D., Skripuletz T., Koutsoudaki P.N., Kotsiari A., Skuljec J., Trebst C., Stangel M. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res. 2009, 1283:127-138.
14. Kipp M., Clarner T., Dang J., Copray S., Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 2009, 118:723-736.
15. Kondo A., Nakano T., Suzuki K. Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res. 1987, 425:186-190.
16. Kotter M.R., Setzu A., Sim F.J., van Rooijen N., Franklin R.J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001, 35:204-212.
17. Kotter M.R., Zhao C., van Rooijen N., Franklin R.J. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 2005, 18:166-175.
18. Kotter M.R., Li W.W., Zhao C., Franklin R.J. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 2006, 26:328-332.
19. Kuhlmann T., Remington L., Maruschak B., Owens T., Bruck W. Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J. Neuropathol. Exp. Neurol. 2007, 66:238-246.
20. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 2003, 100:8514-8519.
21. Li W.W., Setzu A., Zhao C., Franklin R.J. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 2005, 158:58-66.
22. Li X.L., Lv J., Xi N.N., Wang T., Shang X.F., Xu H.Q., Han Z., O'Byrne K.T., Li X.F., Zheng R.Y. Neonatal endotoxin exposure suppresses experimental autoimmune encephalomyelitis through regulating the immune cells responsivity in the central nervous system of adult rats. Biochem. Biophys. Res. Commun. 2010, 398:302-308.
23. Lindner M., Heine S., Haastert K., Garde N., Fokuhl J., Linsmeier F., Grothe C., Baumgartner W., Stangel M. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol. Appl. Neurobiol. 2008, 34:105-114.
24. Lindner M., Trebst C., Heine S., Skripuletz T., Koutsoudaki P.N., Stangel M. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination. Glia 2008, 56:1104-1113.
25. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., Gold R. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 2002, 8:620-624.
26. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
27. Mayer M., Bhakoo K., Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994, 120:143-153.
28. Murphy A.C., Lalor S.J., Lynch M.A., Mills K.H. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2010, 24:641-651.
29. Norenberg W., Cordes A., Blohbaum G., Frohlich R., Illes P. Coexistence of purino- and pyrimidinoceptors on activated rat microglial cells. Br. J. Pharmacol. 1997, 121:1087-1098.
30. Northoff H., Bauer J., Schobert A., Flegel W.A., Gebicke-Haerter P.J. Lipopolysaccharide (LPS)-free conditions allow growth and purification of postnatal brain macrophages (microglia). J. Immunol. Methods 1989, 116:147.
31. Pasquini L.A., Calatayud C.A., Bertone Una A.L., Millet V., Pasquini J.M., Soto E.F. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem. Res. 2007, 32:279-292.
32. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, New York.
33. Pul R., Kopadze T., Skripuletz T., Voss E.V., Kieseier B.C., Stangel M. Polyclonal immunoglobulins (IVIg) induce expression of MMP-9 in microglia. J. Neuroimmunol. 2009, 217:46-50.
34. Pul R., Moharregh-Khiabani D., Skuljec J., Skripuletz T., Garde N., Voss E.V., Stangel M. Glatiramer acetate modulates TNF-alpha and IL-10 secretion in microglia and promotes their phagocytic activity 2010, J, Neuroimmune. Pharmacol.
35. Rasmussen S., Wang Y., Kivisakk P., Bronson R.T., Meyer M., Imitola J., Khoury S.J. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing-remitting experimental autoimmune encephalomyelitis. Brain 2007, 130:2816-2829.
36. Regen,T., van Rossum,D., Scheffel,J., Kastriti,M.E., Revelo,N.H., Prinz,M., Bruck,W., Hanisch,U.K., 2011. CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural variants of LPS. Brain Behav. Immun. (in press).
37. Rehbinder C., Baneux P., Forbes D., van Herck H., Nicklas W., Rugaya Z., Winkler G. FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig, rabbit experimental units. Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health accepted by the FELASA Board of Management, November 1995. Lab. Anim. 1996, 30:193-208.
38. Remington L.T., Babcock A.A., Zehntner S.P., Owens T. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 2007, 170:1713-1724.
39. Serres S., Anthony D.C., Jiang Y., Broom K.A., Campbell S.J., Tyler D.J., van Kasteren S.I., Davis B.G., Sibson N.R. Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J. Neurosci. 2009, 29:4820-4828.
40. Shankaran M., Marino M.E., Busch R., Keim C., King C., Lee J., Killion S., Awada M., Hellerstein M.K. Measurement of brain microglial proliferation rates in vivo in response to neuroinflammatory stimuli: application to drug discovery. J. Neurosci. Res. 2007, 85:2374-2384.
41. Simard A.R., Rivest S. Neuroprotective effects of resident microglia following acute brain injury. J. Comp Neurol. 2007, 504:716-729.
42. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 2008, 172:1053-1061.
43. Skripuletz T., Bussmann J.H., Gudi V., Koutsoudaki P.N., Pul R., Moharregh-Khiabani D., Lindner M., Stangel M. Cerebellar cortical demyelination in the murine cuprizone model. Brain. Pathol. 2010, 20:301-312.
44. Skripuletz T., Miller E., Moharregh-Khiabani D., Blank A., Pul R., Gudi V., Trebst C., Stangel M. Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem. Res. 2010, 35:1422-1433.
45. Sloane E., Ledeboer A., Seibert W., Coats B., van Strien M., Maier S.F., Johnson K.W., Chavez R., Watkins L.R., Leinwand L., Milligan E.D., Van Dam A.M. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav. Immun. 2009, 23:92-100.
46. Stankoff B., Aigrot M.S., Noel F., Wattilliaux A., Zalc B., Lubetzki C. Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 2002, 22:9221-9227.
47. Teeling J.L., Perry V.H. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 2009, 158:1062-1073.
48. Torkildsen O., Brunborg L.A., Myhr K.M., Bo L. The cuprizone model for demyelination. Acta Neurol. Scand. Suppl. 2008, 188:72-76.
49. Turrin N.P., Rivest S. Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J.Neurosci. 2006, 26:143-151.
50. Urbach-Ross D., Kusnecov A.W. Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination. Brain Behav. Immun. 2007, 21:962-974.
51. Wolfson C., Talbot P. Bacterial infection as a cause of multiple sclerosis. Lancet 2002, 360:352-353.